Developer Carter Winstanley has spent the last 22 years working to build up a life science hub in New Haven. In the beginning, he set a modest benchmark for success.
“My original goal was to get 300 George St. leased,” Winstanley says, referencing his transformation of a vacant Southern New England Telephone company building into a high-tech home for Elm City biotechs.
Two decades later, 300 George is at capacity, and two subsequent Winstanley bioscience buildings — 25 Science Park and 100 College St., home of Alexion Pharmaceuticals — are also full.